Investment Articles

  • Better Buy: Eli Lilly or Novo Nordisk?
    Novo Nordisk stock crashed 17% on Friday after revealing disappointing trial results.
  • Is Tesla Stock Still a Buy Today?
    Here's everything you need to know about the electric vehicle maker's week.
  • Finally Some Good News for Intel Stock Investors
    Intel has been struggling to keep up with AMD and Nvidia but there might finally be some good news for investors.
  • With Recent Volatility for the S&P 500 and Nasdaq, Should You Sell Growth Stocks Before 2025?
    Dec. 18 was a big down day in the stock market with the Nasdaq Composite (NASDAQINDEX: ^IXIC) falling 3.6% and the S&P 500 (SNPINDEX: ^GSPC) tumbling 2.9%.The main catalyst for the sell-off was an update from the Federal Reserve that indicated it would slow its pace of rate cuts in 2025, which could keep interest rates high and slow economic growth as a […]
  • Billionaire Seth Klarman Has 42.8% of His Hedge Fund's $3.5 Billion Equities Portfolio Invested in Just 3 Stocks
    Like many of the investing greats, Seth Klarman takes a value approach, in which he tries to find stocks and other assets trading below their intrinsic value and buy them at a discount. Klarman is a firm believer in the lessons taught by Benjamin Graham, who is widely considered the father of value investing.Klarman's fund, the Baupost Group, has done q […]
  • Here's Why Costco Says It Has No Plans to Split Its Stock at $1,000 Per Share
    2024 has been a momentous time for stock splits, with over a dozen leading companies choosing to split their stocks this year.Yet while splitting one's shares seems to be all the rage these days, a few prominent stocks with high share prices have chosen not to participate.Warren Buffett's conglomerate Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) […]
  • Is AbbVie Stock a Buy?
    With its shares offering a total return of nearly 49% over the last three years, trumping the market's return of 33%, AbbVie (NYSE: ABBV) is a powerhouse big pharma that has a lot of upside to offer to investors.While there's no guarantee the next three years of the company's life will outperform the market, there's a solid thesis for why […]

Message
Important Legal Discliamer:
DATA AND RESEARCH IS FOR INFORMATION ONLY, AND IS NOT INTENDED FOR TRADING PURPOSES.

"There are two rules of investing, The first rule is don’t lose. The second rule is don’t forget rule number one!"

~ Benjamin Graham

All contents of the Swing Trading Hub web site are provided for the information and education purposes only and not intended for trading purposes. By accessing the Swingtradinghub.com web site, a user accepts ‘Terms of Use Agreement‘.